On a molecular level, AOD-9604 is compact enough to achieve good solubility in aqueous diluents yet large enough to retain the structural motif needed for its adipocyte-targeting activity
The label starts at 2.5 mg weekly, long-duration obesity evidence starts at 5 mg, and registered human activity has been measured as low as 1 mg in an early diabetes study. Each number answers a different question
Safety evaluation of AOD9604, a synthetic peptide for use in obesity
B12 is poorly absorbed in these conditions, like other nutrients, but its deficiency from poor absorption also contributes to further negative changes in intestinal health
This led us to a debate about how, when you know a bit more about B12 deficiency and Pernicious Anaemia than your GP surgery, it comes as a bit of a surprise when bureaucracy outweighs common sense